3 Under-the-Radar Healthcare Stocks You Should Know About

Dive into how a company like Extendicare Inc (TSX:EXE) helps your portfolio hedge against the aging population in Canada.

| More on:

Anyone can talk about the blue-chip healthcare stocks which garner the attention of financial analysts. However, the real value is in the stocks that no one talks about. As hedge fund manager and value investor Li Lu once said, “To be a better investor, you have to stand on your own. You just can’t copy other people’s insights.” Here are three stocks to help you stand on your own.

Extendicare (TSX:EXE)

Extendicare is a long-term-care facilities and management company focused on senior care. With operations both in Canada and the United States, Extendicare boasts a market capitalization of $706.92 million across its network of 121 healthcare centres. This little-known stock employs approximately 23,000 workers trained in senior care and living under its three brands: Extendicare, Esprit Lifestyle, and ParaMed.

The macroeconomic trend of an aging population in Canada creates a strong market opportunity for this company. Its business sectors have a wide scope to capture the business opportunity created by the increase of Canadian seniors through its operations in nursing care, home care, retirement living, and management and consulting services.

It has seen strong growth since the start of 2019 with the stock trading from $6.49 on December 31 to today’s market open of $8.06. However, over a five-year period, the stock has remained relatively flat with only a 19% increase in price compared to the S&P 500’s increase of 55% over the same period.

By announcing the addition of private equity firm Sandpiper to its board of directors on April 22, 2019, Extendicare becomes a stock to watch more closely. It will be a point of interest for investors to see how it can find new ways to tap potential.

BELLUS Health (TSX:BLU)

BELLUS Health is a Quebec-based biopharmaceutical company focused on novel treatments for disorders related to hypersensitization, most notably therapeutics for chronic cough. Like Extendicare, it operates in a growing macroeconomic environment where approximately 26 million adults in the United States suffer from a chronic cough.

The selling point for biopharma companies are the monopoly-like patents on drugs or therapeutics. For BELLUS, this major competitive advantage comes in the form of its lead drug candidate, BLU-5937. Following its successful phase one clinical study, BELLUS expects to initiate its clinical phase two study in chronic cough patients by mid-2019, with top-line results anticipated in mid-2020. This should give investors a solid timeline on when to expect volatility in the stock.

BELLUS carries a market cap of $213.242 million with a negative beta of -0.03. This presents investors with an interesting opportunity to hedge against the market using this stock.

VieMed (TSX:VMD)

VieMed has an exciting outlook without creating much press. Its core business is conducted through two wholly-owned subsidiaries Home Sleep Delivered and Sleep Management. VieMed specializes in supplying home medical equipment to patients with post-acute respiratory diseases in the United States. VieMed, like its two previously mentioned counterparts, is also a beneficiary of the aging population.

As the largest independent specialized provider of non-invasive ventilation in the United States, VieMed boasts strong financial metrics to couple with its attractive industry growth opportunity. Investors have enjoyed a healthy 42% price growth in the past year and can remain positive with the industry growth opportunity being so attractive.

In the next 19 years, an average of 10,000 people will turn 65 on a daily basis. This will cause U.S. healthcare expenditures in the respiratory disease space to grow from $46.5 billion at a 5.3% CAGR until 2020.

Finding value in hidden gems

As an investor, you should already have a clear idea of what industry you like to invest in. If it happens to be healthcare, these three stocks should provide some insight on stocks that don’t get much attention from financial analysts. However, to find true value, one must look where no one else does.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris Fabian has no position any of the stocks mentioned. The Motley Fool owns shares of Viemed Healthcare Inc. Viemed Healthcare Inc. is a recommendation of Hidden Gems Canada.

More on Investing

Stacked gold bars
Metals and Mining Stocks

B2Gold: Buy, Sell, or Hold in July 2025?

B2Gold has churned out positive news so far in July. Here's how I'd "trade" the TSX gold stock this month.

Read more »

woman checks off all the boxes
Dividend Stocks

CPP Collectors: Here Are 3 More Red Flags the CRA is Watching

Worried about the CRA? Stop immediately by taking these steps and investing wisely.

Read more »

Financial analyst reviews numbers and charts on a screen
Stocks for Beginners

1 Stellar Canadian Stock Down 47% From Its All-Time High to Buy and Hold Forever

Down sharply from its peak, this top Canadian stock is setting itself up for a long-term comeback backed by a…

Read more »

some REITs give investors exposure to commercial real estate
Stocks for Beginners

A 3.4% Dividend Yield? I’m Buying This Dividend Darling and Holding for Decades

Grab this dividend yield while it lasts, and never worry again while holding the top choice on the market!

Read more »

Person holding a smartphone with a stock chart on screen
Dividend Stocks

This 7.4% Dividend Stock Is My Top Pick for Immediate Income

With a solid 7.4% dividend yield, a proven history of dividend growth, and strong fundamentals, it offers both stability and…

Read more »

Hand Protecting Senior Couple
Dividend Stocks

How Should Canadians Calculate the Perfect Retirement Income for Maximum Benefits

Here's how Canadians should calculate the perfect retirement income for maximum benefits.

Read more »

Train cars pass over trestle bridge in the mountains
Dividend Stocks

1 Canadian Railway Stock That’s Built for the Long Haul

A Canadian railway stock with solid growth fundamentals and a network that connects a continent is built for the long…

Read more »

Piggy bank on a flying rocket
Energy Stocks

The 6% Dividend Champion Built for Income Investors

Income investors seeking a great stock that can provide both growth and income over the longer term should strongly consider…

Read more »